Literature DB >> 17008597

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Kurt R Stenmark1, Karen A Fagan, Maria G Frid.   

Abstract

Chronic hypoxic exposure induces changes in the structure of pulmonary arteries, as well as in the biochemical and functional phenotypes of each of the vascular cell types, from the hilum of the lung to the most peripheral vessels in the alveolar wall. The magnitude and the specific profile of the changes depend on the species, sex, and the developmental stage at which the exposure to hypoxia occurred. Further, hypoxia-induced changes are site specific, such that the remodeling process in the large vessels differs from that in the smallest vessels. The cellular and molecular mechanisms vary and depend on the cellular composition of vessels at particular sites along the longitudinal axis of the pulmonary vasculature, as well as on local environmental factors. Each of the resident vascular cell types (ie, endothelial, smooth muscle, adventitial fibroblast) undergo site- and time-dependent alterations in proliferation, matrix protein production, expression of growth factors, cytokines, and receptors, and each resident cell type plays a specific role in the overall remodeling response. In addition, hypoxic exposure induces an inflammatory response within the vessel wall, and the recruited circulating progenitor cells contribute significantly to the structural remodeling and persistent vasoconstriction of the pulmonary circulation. The possibility exists that the lung or lung vessels also contain resident progenitor cells that participate in the remodeling process. Thus the hypoxia-induced remodeling of the pulmonary circulation is a highly complex process where numerous interactive events must be taken into account as we search for newer, more effective therapeutic interventions. This review provides perspectives on each of the aforementioned areas.

Entities:  

Mesh:

Year:  2006        PMID: 17008597     DOI: 10.1161/01.RES.0000243584.45145.3f

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  409 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

2.  Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.

Authors:  Rebecca R Vanderpool; Ah Ram Kim; Robert Molthen; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2010-11-18

3.  The aquaporin 1 C-terminal tail is required for migration and growth of pulmonary arterial myocytes.

Authors:  Ning Lai; Julie Lade; Kyle Leggett; Xin Yun; Syeda Baksh; Eric Chau; Michael T Crow; Venkataramana Sidhaye; Jian Wang; Larissa A Shimoda
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

4.  Recapitulation of developing artery muscularization in pulmonary hypertension.

Authors:  Abdul Q Sheikh; Janet K Lighthouse; Daniel M Greif
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 5.  Measuring high-altitude adaptation.

Authors:  Lorna G Moore
Journal:  J Appl Physiol (1985)       Date:  2017-08-31

6.  Contribution of increased VEGF receptors to hypoxic changes in fetal ovine carotid artery contractile proteins.

Authors:  Olayemi O Adeoye; Stacy M Butler; Margaret C Hubbell; Andrew Semotiuk; James M Williams; William J Pearce
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-16       Impact factor: 4.249

7.  Chronic hypoxia alters fetal cerebrovascular responses to endothelin-1.

Authors:  Jinjutha Silpanisong; Dahlim Kim; James M Williams; Olayemi O Adeoye; Richard B Thorpe; William J Pearce
Journal:  Am J Physiol Cell Physiol       Date:  2017-05-31       Impact factor: 4.249

8.  The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.

Authors:  Rachel E Nisbet; Anitra S Graves; Dean J Kleinhenz; Heidi L Rupnow; Alana L Reed; Tai-Hwang M Fan; Patrick O Mitchell; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-23       Impact factor: 6.914

9.  Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression.

Authors:  Diana Klein; Jennifer Steens; Alina Wiesemann; Florian Schulz; Farnusch Kaschani; Katharina Röck; Masahiro Yamaguchi; Florian Wirsdörfer; Markus Kaiser; Jens W Fischer; Martin Stuschke; Verena Jendrossek
Journal:  Antioxid Redox Signal       Date:  2016-11-14       Impact factor: 8.401

Review 10.  Fetal Physiology and the Transition to Extrauterine Life.

Authors:  Sarah U Morton; Dara Brodsky
Journal:  Clin Perinatol       Date:  2016-06-11       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.